Loading…
Disclosed for 2 months, Jan 2014 to Feb 2014. This scheme is no longer reporting.
UTI - Master Value Fund is an active equity fund in the Value / Contra category from UTI Mutual Fund. In January 2014 it disclosed 73 stocks worth ₹501 Cr. Its largest positions were HCL Technologies Limited (4.8%), Indoco Remedies Limited (4.0%), Pidilite Industries Limited (3.4%); the ten largest together made up 32.2% of the portfolio, and IT - Software was the biggest sector at 10.1% of its equity. Cash and debt stood at 1.6%.
Top-10 weight is higher than 37% of peers
Holds more stocks than 81% of peers
Holds more cash than 22% of peers
What these mean: concentration · cash
Every line the fund disclosed, with the change against the previous month. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
This is the earliest month on record for the fund.
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
No earlier month with a sector split to compare against.
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Not enough months to draw.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.